Protein-and lipid-linked complex-type oligosaccharide chains are commonly based on GalPl-+ 4GlcNAc (N-acetyl-lactosamine, lacNAc) units that serve as backbone structural elements. However, in an increasing number of instances GalNAca 1 -+ 4GlcNAc (4"-diacetyl-lactosdiamine, 1acdiNAc) units rather than lacNAc units are found on the N-and 0-linked oligosaccharide chains of glycoproteins ([l-241; see Table 1 ). The group of glycoproteins that carry such chains is quite diverse and comprises inter alia hormones, enzymes, membrane glycoproteins and transport proteins. It appears that lacdiNAc-type chains particularly occur on glycoproteins of lower animal species, but are also present along with lacNAc-type chains on mammalian glycoproteins. Like the lacNAc unit in complex-type oligosaccharide structures, lacdiNAc units may be capped by terminal NeuAc residues in a2-3-or a2-6-linkage [S-121. They also may contain a Fuc residue in a 1 -+
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to form the lacdiNAc analogue of the Lewis" blood group antigenic structure [3, 12, . By contrast, when sulphate is present at Gal in lacNAc it is substituted at C-3 exclusively [25, 26] , while sulphate in lacdiNAc-type structures occurs linked to C-4 of GalNAc [13] [14] [15] [16] [17] [18] . a3-Galactosylated lacNAc units are quite common to glycoconjugates of several mammalian species [27] , but so far no a3-galactosylated lacdiNAc has been described. In turn the lacdiNAc unit in lower animals may be substituted with tyvelose (Tyv) [23] , or methylated or fucosylated Gal residues [24] , substitutions which are unknown for lacNAc.
The synthesis of lacdiNAc units appear to be controlled by an UDP-Ga1NAc:GlcNAcp-R p4-Nacetylgalactosaminyltransferase (P4-GalNAcT). An enzyme having such an activity has been described in pituitary glands where it functions in the glycosylation of certain pituitary hormones "281. Evidence has been presented to suggest that this enzyme is specific for such hormones by its specific recognition of a Pro-Xaa-Arg/Lys sequence 6-9 amino acids upstream of the N-glycosylation site of these glycoproteins [29] . Highly active P4-GalNAcTs have recently been found in the albumen gland of the snail Lymnaea stagnalis [30] and in Table 1 Occurrence and terminal substitution of the LacdiNAc unit on N-and 0-linked glycoprotein glycans different stages (cercariae, miracidia and mother sporocysts) of the avian schistosome Trichobilharzza ocelluta [3 11 . Characterization of the latter GalNAcTs showed that these enzymes are capable of acting on GlcNAc residues at the non-reducing end of oligosaccharides, whether free or proteinbound, regardless of the underlying structure (Table  2 ). In this respect and by kinetic analysis with different oligosaccharide and glyco(po1y)peptide acceptors ihese p4-GalNAcTs clearly differ from the pituitary enzyme. Furthermore, by use of specific acceptor substrates, the schistosomal P4-GalNAcT could be readily distinguished from all other 84-GalNAcTs described to date, such as those involved in the synthesis of the Sd" blood group determinant, ganglioside GM, and chondroitin sulphate [3 11 . In several enzymic properties, however, the P4-GalNAcT rather resembles the 84-galactosyltransferase (64-GalT) that is common to mammalian species and that is known to control the synthesis of lacNAc units on N-and O-glycoproteins as well as on glycolipids (321.
A mammalian version of the snail and schistosoma1 (hormone unspecific) P4-GalNAcTs seems to be present in human embryonic kidney and in several malignant cell lines [33] . In turn a P4-GalT has been found in schistosomes [ 341. Because of the similarity in acceptor properties of P4-GalT and P4-GalNAcT it has been proposed that there might be competition for common substrate sites in cells 
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Asialo/agalacto-a ,-acid glycoprotein 41 *GP-F2 is a di-antennary glycopeptide having the following structure: GlcNAcBI -2Mana I -6(GlcNAcj3I -2Mana I -3)- that express both these enzymes [31, 35] (Figure 1 ).
With the future goal of studying the control of The expression levels of each of these enzymes the IacdiNAc pathway on a molecular biological would determine whether lacNAc-or 1acdiNAc-level, the isolation of a cDNA encoding P4-Galtype chains will prevail on the glycoprotein NAcT was attempted. The resemblance in enzymic products of such cells.
properties of the B4-GalT and the B4-GalNAcT
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prompted us to try this by screening of a L. stagnalis genomic library using a cDNA coding for bovine P4-GalT [36] as a probe. Under low-stringency conditions hybridizing DNA fragments were obtained that were used to probe snail cDNA libraries. A full-length cDNA clone was isolated from a snail prostate gland library that showed an open reading frame of 1470 bp. In all respects the deduced amino acid sequence, representing a protein of 490 amino acids, showed a domain topology typical for a glycosyltransferase [37] . From an albumen gland library a cDNA fragment was isolated that lacked about 350 bp at its 5' end. This partial cDNA showed approx. 70% sequence identity with the prostate cDNA. The deduced amino acid sequences of these two snail cDNAs contained several regions that showed considerable similarity with corresponding exons in the murine P4-GalT genome [38] . Highest similarity (up to 56%) was found in the regions that constitute the putative catalytic domain. Considering the evolutionary distance between snails and mammals, and the fact that essentially no P4-GalT activity can be detected in L. stagnalis, this is quite remarkable. It suggests that the glycosyltransferases encoded by the isolated snail cDNAs are evolutionarily related to p4-GalT and that the genes of these enzymes and of P4-GalT may have evolved from a common ancestor. This would show that these enzymes constitute yet another glycosyltransferase family in addition to those that have been identified to date [35] . Studies are in progress to identify the enzymes that are represented by these snail cDNAs. It is expected that one of these cDNAs encodes a 84-GalNAcT that is involved in the synthesis of IacdiNAc-based structures.
Further processing of lacdiNAc chains shows analogy with that of IacNAc-based chains. It has been demonstrated that Galpl-. 4GlcNAc-specific a6-sialyltransferases can also act on lacdiNAc to form NeuAca2 -. 6GalNAcpl-4GlcNAc [ 39-41 1.
Similarly it has been found that human milk a3(4)-fucosyltransferase can act on this disaccharide to yield the IacdiNAc analogue of Lewis" (GalNAcp1-4[Fuca 1 -. 31GlcNAc) [42] . Furthermore a sulphotransferase has been identified in pituitary gland that catalyses the transfer of sulphate to C-4 of GalNAc in lacdiNAc [43] , and a 83-galactosyltransferase has been described catalysing the formation of GalPl-. 3GalNAcp1-4GlcNAc [44] . However, glycosyltransferase-catalysed additions of a-NeuAc [41] , a-Gal and /3-GlcNAc, that readily occur to C-3 of Gal residues in IacNAc, have appeared to proceed at very low rates if at all to C-3 Little is known about the biological significance of IacdiNAc-based oligosaccharide chains. It has been reported that a specific hepatic reticuloendothelial receptor for S04--4GalNAc/?1 + 4GlcNAcp-R exists that mediates the rapid clearance of the glycohormone lutropin [45] . It has also been suggested that the lacdiNAc-based Lewis' analogue structure present on the oligosaccharide chains of protein C plays a role in the anti-inflammatory effect of this protein [46] . In addition it has been proposed [ 3 11 that IacdiNAc-type oligosaccharide chains at the surface of schistosomes might create a molecular mimicry that contributes to the evasion of the defence system of the snail host resulting in successful infection [47, 48] . It will be of interest to investigate whether other terminal structures formed in the lacdiNAc pathway likewise confer specific functions and properties on the glycoconjugates carrying them.
Note added in proof (received 2 December 1994)
Recently it has appeared that the prostate cDNA encodes a novel UDP-GlcNAc:GlcNAc~-R Nacetylglucosaminyltransferase. This enzyme might be involved in yet another variant (the 'chitobio' pathway) of complex-type glycan processing [48a] .
